Moreover, the secretion of IL-1β can recruit immunosuppressive cells, such as regulatory T cells and M2 macrophages (Xue et al., 2019), that can inhibit the anti-tumor immune response, and promote angiogenesis and matrix remodeling, providing tumor progression. This evidence concerns the gene IL1B and neoplasm.